GHU Logo
The Great Heights University Library
Academic discovery, digital access, and research support

Computational Modeling of Drugs Against Alzheimer’s Disease (Record no. 6459)

MARC details
000 -LEADER
fixed length control field 05357nam a22005775i 4500
001 - CONTROL NUMBER
control field 978-1-0716-3311-3
003 - CONTROL NUMBER IDENTIFIER
control field DE-He213
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20260610083647.0
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr nn 008mamaa
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 230630s2023 xxu| s |||| 0|eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781071633113
-- 978-1-0716-3311-3
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1007/978-1-0716-3311-3
Source of number or code doi
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number RC321-580
072 #7 - SUBJECT CATEGORY CODE
Subject category code PSAN
Source bicssc
072 #7 - SUBJECT CATEGORY CODE
Subject category code SCI089000
Source bisacsh
072 #7 - SUBJECT CATEGORY CODE
Subject category code PSAN
Source thema
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 612.8
Edition information 23
245 10 - TITLE STATEMENT
Title Computational Modeling of Drugs Against Alzheimer’s Disease
Medium [electronic resource] /
Statement of responsibility, etc. edited by Kunal Roy.
250 ## - EDITION STATEMENT
Edition statement 2nd ed. 2023.
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Place of production, publication, distribution, manufacture New York, NY :
Name of producer, publisher, distributor, manufacturer Springer US :
-- Imprint: Humana,
Date of production, publication, distribution, manufacture, or copyright notice 2023.
300 ## - online resource
Extent XVII, 493 p. 176 illus., 122 illus. in color.
Other physical details online resource.
336 ## - CONTENT TYPE
Content type term text
Content type code txt
Source rdacontent
337 ## - MEDIA TYPE
Media type term computer
Media type code c
Source rdamedia
338 ## - CARRIER TYPE
Carrier type term online resource
Carrier type code cr
Source rdacarrier
341 0# - ACCESSIBILITY CONTENT
Textual assistive features Table of contents navigation
Source onix
341 0# - ACCESSIBILITY CONTENT
Textual assistive features Single logical reading order
Source onix
341 0# - ACCESSIBILITY CONTENT
Textual assistive features Short alternative textual descriptions
Source onix
341 0# - ACCESSIBILITY CONTENT
Textual assistive features Use of color is not sole means of conveying information
Source onix
341 0# - ACCESSIBILITY CONTENT
Textual assistive features Use of high contrast between text and background color
Source onix
341 0# - ACCESSIBILITY CONTENT
Textual assistive features Next / Previous structural navigation
Source onix
341 0# - ACCESSIBILITY CONTENT
Textual assistive features All non-decorative content supports reading without sight
Source onix
347 ## - DIGITAL FILE CHARACTERISTICS
File type text file
Encoding format PDF
Source rda
490 1# - SERIES STATEMENT
Series statement Neuromethods,
International Standard Serial Number 1940-6045 ;
Volume/sequential designation 203
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note Recent Progress in the Treatment Strategies of Alzheimer’s Disease -- Understanding the Mechanisms of Amyloid Beta (Aβ) Aggregation by Computational Modeling -- Recent Advances in Computational Modeling of BACE1 Inhibitors as Anti-Alzheimer Agents -- Modeling of BACE-1 Inhibitors as Anti-Alzheimer’s Agents -- Computational Modeling of Kinase Inhibitors as Anti-Alzheimer Agents -- Computer-Assisted Drug Design: A Toolbox for Novel Tau Kinase Inhibitors and Its Implications in Alzheimer’s Disease -- Computational Modeling Approaches in Search of Anti-Alzheimer Agents: Case Studies of Phosphodiesterase Inhibitors -- Recent Advances in Computational Modeling of Multi-Targeting Inhibitors as Anti-Alzheimer Agents -- Computational Modeling of PET and SPECT Imaging Agents as Diagnostics for Alzheimer’s Disease -- Computational Modeling of DYRK1A Inhibitors as Potential Anti-Alzheimer Agents -- Computational Modeling of MAO Inhibitors as Anti-Alzheimer Agents -- Computational Modeling of Phosphodiesterase Inhibitors as Anti-Alzheimer Agents -- Computational Methods for the Design and Development of Glutaminyl Cyclase Inhibitors in Alzheimer’s Disease -- Basic Information Science Methods for Insight into Neurodegenerative Pathogenesis -- Network Pharmacology for Drug Repositioning in Anti-Alzheimer's Drug Development -- Web Services for the Prediction of ADMET Parameters Relevant to the Design of Neuroprotective Drugs.
520 ## - SUMMARY, ETC.
Summary, etc. This second edition volume expands on the previous edition with updated descriptions on different computational methods encompassing ligand-based, structure-based, and combined approaches with their recent applications in anti-Alzheimer drug design. Different background topics like recent advancements in research on the development of novel therapies and their implications in the treatment of Alzheimer’s Disease (AD) have also been covered for completeness. Special topics like basic information science methods for insight into neurodegenerative pathogenesis, drug repositioning and network pharmacology, and online tools to predict ADMET behavior with reference to anti-Alzheimer drug development have also been included. In the Neuromethods series style, chapter include the kind of detail and key advice from the specialists needed to get successful results in your laboratory. Cutting-edge and thorough, Computational Modeling of Drugs Against Alzheimer’s Disease, Second Edition is a valuable resource for all researchers and scientists interested in learning more about this important and developing field.
532 8# - ACCESSIBILITY NOTE
Summary of accessibility Accessibility summary: This PDF does not fully comply with PDF/UA standards, but does feature limited screen reader support, described non-text content (images, graphs), bookmarks for easy navigation and searchable, selectable text. Users of assistive technologies may experience difficulty navigating or interpreting content in this document. We recognize the importance of accessibility, and we welcome queries about accessibility for any of our products. If you have a question or an access need, please get in touch with us at accessibilitysupport@springernature.com.
532 8# - ACCESSIBILITY NOTE
Summary of accessibility No reading system accessibility options actively disabled
532 8# - ACCESSIBILITY NOTE
Summary of accessibility Publisher contact for further accessibility information: accessibilitysupport@springernature.com
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Neurosciences.
650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Neuroscience.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Roy, Kunal.
Relator term editor.
Relationship edt
-- http://id.loc.gov/vocabulary/relators/edt
710 2# - ADDED ENTRY--CORPORATE NAME
Corporate name or jurisdiction name as entry element SpringerLink (Online service)
773 0# - HOST ITEM ENTRY
Title Springer Nature eBook
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Relationship information Printed edition:
International Standard Book Number 9781071633106
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Relationship information Printed edition:
International Standard Book Number 9781071633120
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Relationship information Printed edition:
International Standard Book Number 9781071633137
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE
Uniform title Neuromethods,
International Standard Serial Number 1940-6045 ;
Volume/sequential designation 203
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1007/978-1-0716-3311-3">https://doi.org/10.1007/978-1-0716-3311-3</a>
912 ## -
-- ZDB-2-PRO

No items available.